Thomas,
Here are excerpts from information that may be of interest to you on the subject of anaphlaxsis, including this working definition accepted by the medical community. Please note!!! this is NOT medical advice, just information.
From Current Opinion in Allergy and Clinical Immunology
"Understanding the Mechanisms of Anaphylaxis"
Posted 09/22/2008
Author Information:
Richard D. Peavy and Dean D. Metcalfe, Laboratory of Allergic Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
[Anaphylaxis and insect allergy: Edited by Theodore Freeman, Jacobs, Ramirez, and Freeman Allergy & Immunology Associates and Alessandro Fiocchi]
"With the initiative of the National Institute of Allergy and Infectious Diseases and the Food Allergy and Anaphylaxis Network, representatives from several organizations in the United States and abroad met in symposia in 2004 and 2005 to debate and seek consensus on a universally accepted definition and clinical criteria for identification of anaphylaxis. The outcomes of these symposia were published in two reports in the Journal of Allergy and Clinical Immunology.[2,3] In seeking a definition both useful and accessible to the lay public, the participants proposed simply that, 'Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.' Even more significant for emergency response and treatment, the participants established a set of three diagnostic criteria for anaphylaxis to include observations of skin and mucosal tissue symptoms, respiratory distress, reduced blood pressure, and/or gastrointestinal symptoms over a time course of minutes to hours after exposure to allergen.[2,3]"
"The most frequently identified triggers for anaphylaxis include foods (especially peanuts and tree nuts), drugs (antibiotics, vaccines, medications, and anesthetics), insect venoms, latex, and allergen immunotherapy injections.[3,14] There is also a significant number of anaphylaxis cases reported for which there is no cause identified (idiopathic anaphylaxis).[15,16]'
Self-Injectable Epinephrine for Initial Management of Anaphylaxis in Children
Posted 09/09/2008
Marcia L. Buck, Pharm.D., FCCP; Kristi N. Hofer, Pharm.D.; Michelle W. McCarthy, Pharm.D.
"It has been estimated that 1 to 2% of the population is at risk for anaphylaxis.[1,2] Intramuscular (IM) administration of epinephrine is the primary therapy in the emergency management of anaphylaxis resulting from insect bites or stings, foods, drugs, latex, or other allergic triggers. Its efficacy lies in prompt administration after allergen exposure. Self-injectable epinephrine products have been designed for administration within minutes of the onset of symptoms. In children, these products may be administered by a parent or other trained personnel. This issue of Pediatric Pharmacotherapy will review of the role epinephrine in anaphylaxis and highlight current recommendations on the use of self or caregiver-administered epinephrine in children."...................from the same article:
"Position Statements and Practice Guidelines"
In 2002, the American Academy of Allergy, Asthma, and Immunology (AAAAI) published an updated position statement on the use of epinephrine in the treatment of anaphylaxis.[8] This statement included the following recommendations:
* Prescribers need to be aware of patients' previous allergic reactions. Self-injectable epinephrine should be considered in all patients with a previous history of anaphylaxis or a serious reaction to an allergen. Patients and/or caregivers should be provided with detailed instructions regarding methods for identification and avoidance of allergens, as well as a treatment plan.
* If the patient is not capable of self-administration, epinephrine should be given by any individual recognizing the presence of an emergency need. The Academy supports authorization of trained personnel to administer epinephrine, including lifeguards, teachers, and camp counselors.
* Paramedics should receive training in the recognition and treatment of anaphylaxis. They should be certified to administer epinephrine, based on individual state requirements.
* Intramuscular epinephrine should be included in emergency medical kits in all public facilities.
* It is recommended that epinephrine be available in all schools for use by nurses or other trained staff.
Similar recommendations were published last year by the European Academy of Allergology and Clinical Immunology.[9] Like the AAAAI recommendations, this group supported the use of IM epinephrine as a first-line therapy in children. The group called for the development of anaphylaxis management plans tailored to the individual child, based on previous allergic reactions, other medical conditions, and social circumstances. They recommend that self-injectable epinephrine be prescribed for all children with prior cardiorespiratory reactions, exercise-induced anaphylaxis, idiopathic anaphylaxis, and persistent asthma in children with food allergies.
In March 2007, the American Academy of Pediatrics published a clinical practice guideline on the use of self-injectable epinephrine.[3] This document provides a thorough review of the literature and addresses some of the controversies in the care of pediatric patients, including symptom identification and epinephrine dosing in children weighing less than 15 kg, for whom standard auto-injectors may provide an excessive dose.".......................
"Drug Interactions
Epinephrine should used with caution in patients taking digoxin, quinidine, diuretics, or other alpha or beta-adrenergic agonists, as concomitant administration may lead to arrhythmias or hypertension. The effects of epinephrine may be increased when given with antihistamines, furazolidone, levothyroxine, methyldopa, reserpine, tricyclic antidepressants, or monoamine oxidase inhibitors.[4-6]